Skip to main content

Featured Studies

Office of Patient Recruitment

This web page makes it easy to search for featured research studies at the NIH Clinical Center. You can search for specific studies by entering keywords related to your symptoms in the search box or by using the sort and filter options.


To view a full list of all studies conducted at the NIH Clinical Center, visit Search the Studies.

Filter By

Visit Type

Patient or Healthy Volunteer

Age Group

Institution

Web Page Language

Reset All Filters
6 results
An Open-Label Phase 3 Study of the Safety and Efficacy of Pegvisomant in Children with Growth Hormone Excess

An Open-Label Phase 3 Study of the Safety and Efficacy of Pegvisomant in Children with Growth Hormone Excess

Gigantism is a condition characterized by excessive growth and height significantly above average, caused by over-production of growth hormone (GH) during childhood. Investigators at the National Institutes of Health (NIH) want to see if a drug that antagonizes growth hormone action, called pegvisomant, can help children and adolescents with gigantism.
Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 19-CH-0071.
Children's Growth and Behavior Study

Children's Growth and Behavior Study

Researchers at the NIH Clinical Center are seeking healthy children for a study of growth and health behaviors. The purpose of the study is to better understand growth in children and adolescents.
Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 15-CH-0096.
Clinical Evaluation of Pediatric and Adults with Myelodysplastic Syndromes (MDS)

Clinical Evaluation of Pediatric and Adults with Myelodysplastic Syndromes (MDS)

Myelodysplastic syndromes (MDS) are disorders caused by abnormal blood cell production, potentially leading to low cell counts and increased susceptibility to clotting and infections. Past research suggests that inflammation may trigger these abnormalities, and this study seeks to further understand and improve treatment strategies for MDS by investigating the role of inflammation in bone marrow cell development.

Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 000661-C.
Was this page helpful?